ASD diagnosis 2024

The dataset for this retrospective study was derived from the medical records of an autism center within a public hospital in Israel, specifically analyzing data from 91 children and adolescents aged 6 to 18 who were referred for comprehensive multidisciplinary ASD evaluations. Of this initial cohort, a sub-sample of 84 individuals provided full data for the final analysis, comprising a gender distribution of 73 boys and 18 girls with a mean age of 11.67 years at the time of their clinic visit. The data collection process integrated multiple sources including standardized teacher and parent questionnaires, in-depth developmental histories regarding the age of first concern, and clinical assessments conducted by experienced physicians and psychologists using tools such as the Autism Diagnostic Observation Schedule, Second Edition (ADOS-2) and the Social Attribution Test (SAT). Additionally, the dataset encompassed specific DSM-5 diagnostic criteria, indicators of atypical development, and information on comorbidities such as ADHD and anxiety, alongside records of pharmacological interventions and independent diagnostic opinions from the clinical team.

本回顾性研究所用数据集来源于以色列某公立医院下属自闭症诊疗中心的医疗记录，针对91名6至18岁、被转诊接受全面多学科自闭症谱系障碍（Autism Spectrum Disorder, ASD）评估的儿童与青少年展开分析。初始队列中，84名个体组成的亚样本提供了完整数据用于最终分析；该亚样本性别分布为73名男性、18名女性，门诊就诊时的平均年龄为11.67岁。数据收集流程整合了多类来源：标准化教师与家长问卷、关于首次关注发育异常年龄的详细发育史，以及由资深医师与心理学家采用自闭症诊断观察量表第二版（ADOS-2）、社会归因测验（SAT）等工具开展的临床评估。此外，该数据集还涵盖了《精神障碍诊断与统计手册第五版》（DSM-5）规定的特定诊断标准、非典型发育指标、注意缺陷多动障碍（Attention Deficit Hyperactivity Disorder, ADHD）与焦虑等共病信息，以及药物干预记录与临床团队出具的独立诊断意见。